![]() |
市場調查報告書
商品編碼
1541554
2024-2032 年按手術(開放手術、微創手術)、產品(經導管主動脈瓣、無縫線瓣膜等)、最終用途(醫院、門診手術中心等)和地區分類的主動脈瓣置換市場報告Aortic Valve Replacement Market Report by Surgery (Open Surgery, Minimally Invasive Surgery), Product (Transcatheter Aortic Valve, Sutureless Valve, and Others), End Use (Hospitals, Ambulatory Surgery Centers, and Others), and Region 2024-2032 |
IMARC Group年全球主動脈瓣置換市場規模達102億美元。主動脈疾病的盛行率不斷上升、健康保險政策的不斷實施以及 MIS 程序的日益採用是推動市場的一些關鍵因素。
主動脈瓣置換術是一種用於更換心臟中生病或受損的主動脈瓣的外科手術。它通常透過傳統的心臟直視手術進行操作,涉及切開胸部或使用微創(MI)方法,需要在胸部做較小的切口或在腿部植入導管。它可以治療影響瓣膜並控制流經心臟的血液的疾病。它有助於恢復正常的血流、減輕症狀、延長壽命並維持心肌功能。通常建議患有嚴重主動脈瓣疾病的患者,包括主動脈瓣狹窄或主動脈瓣關閉不全,並有胸痛、氣短和疲勞等症狀。
主動脈疾病在大眾中的盛行率激增以及人口老化的加劇(更容易患上這些疾病)是推動全球主動脈瓣置換術需求的主要因素之一。此外,為主動脈瓣置換術提供經濟援助並減少醫療費用的健康保險政策的持續實施也有利於市場的成長。此外,人們對主動脈疾病及其症狀、診斷的認知不斷提高,以及主動脈瓣置換術等治療方案的便利性正在對市場產生積極影響。除此之外,經導管主動脈瓣置換術(TAVR) 的採用率有所增加,這是一種微創外科(MIS) 手術,可幫助在不進行心臟直視手術的情況下更換主動脈瓣,並且通常受到有重大風險的患者的青睞。再加上由於手術併發症更少、住院時間更短、疼痛更少、術後護理更少、恢復更快和感染風險更低,人們對 MIS 手術的偏好不斷上升,正在推動市場的成長。此外,人工智慧(AI)和機器學習(ML)在主動脈瓣置換成像技術中的整合,可以識別併發症風險較高的患者,並最佳化手術和術後護理,也有助於市場成長。除此之外,許多國家的管理機構正在採取措施,為所有人提供優質的醫療保健設施。這與診斷技術的顯著改進一起,正在加強市場的成長。
The global aortic valve replacement market size reached US$ 10.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 25.0 Billion by 2032, exhibiting a growth rate (CAGR) of 10.1% during 2024-2032. The increasing prevalence of aortic diseases, rising implementation of health insurance policies, and the growing adoption of MIS procedures represent some of the key factors driving the market.
Aortic valve replacement is a surgical procedure performed to replace a diseased or damaged aortic valve in the heart. It is usually operated through the traditional open-heart surgery, which involves incising the chest or using minimally invasive (MI) methods that require smaller incisions in the chest or a catheter incorporated in the leg. It treats diseases that affect the valves and controls blood flow through the heart. It aids in restoring normal blood flow, reducing symptoms, prolonging life, and preserving the function of the heart muscle. It is generally recommended for patients with severe aortic valve disease, including aortic stenosis or aortic regurgitation, that has symptoms like chest pain, shortness of breath, and fatigue.
The surging prevalence of aortic diseases among the masses and the increasing aging population that is more prone to developing these medical disorders represent one of the major factors driving the demand for aortic valve replacement around the world. Moreover, the rising implementation of health insurance policies that offer financial assistance for aortic valve replacement and reduce medical expenses is favoring the growth of the market. In addition, the growing awareness about aortic diseases, their symptoms, diagnosis, and the easy availability of the treatment options like aortic valve replacement is influencing the market positively. Apart from this, there is an increase in the adoption of transcatheter aortic valve replacement (TAVR), minimally invasive surgical (MIS) procedure that helps replace the aortic valve without open-heart surgery and is generally preferred by patients who are at major risk for traditional open-heart surgery. This, coupled with the rising preferences for MIS procedures on account of fewer operative complications, shorter hospitalization, less pain, reduced postoperative care, quicker recovery, and lower risk of infection, is propelling the growth of the market. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) in imaging techniques of aortic valve replacement to identify patients who are at higher risk for complications and optimize the procedure and postoperative care is contributing to the market growth. Besides this, governing agencies of numerous countries are undertaking measures to offer quality healthcare facilities that are accessible to all. This, along with significant improvements in the diagnostic technologies, is strengthening the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global aortic valve replacement market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on surgery, product and end use.
Open Surgery
Minimally Invasive Surgery
The report has provided a detailed breakup and analysis of the aortic valve replacement market based on the surgery. This includes open surgery and minimally invasive surgery. According to the report, minimally invasive surgery represented the largest segment.
Transcatheter Aortic Valve
Sutureless Valve
Others
A detailed breakup and analysis of the aortic valve replacement market based on the product has also been provided in the report. This includes transcatheter aortic valve, sutureless valve, and others. According to the report, transcatheter aortic valve accounted for the largest market share.
Hospitals
Ambulatory Surgery Centers
Others
The report has provided a detailed breakup and analysis of the aortic valve replacement market based on the end use. This includes hospitals, ambulatory surgery centers, and others. According to the report, hospitals represented the largest segment.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for aortic valve replacement. Some of the factors driving the North America aortic valve replacement market included extensive research and development (R&D) activities, well established healthcare facilities, integration of advanced technologies, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global aortic valve replacement market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Anteris Technologies Ltd., Boston Scientific Corporation, Coroneo Inc., CryoLife Inc., Edward Lifesciences Corporation, JenaValve Technology Inc., LifeNet Health Inc., LivaNova PLC, Medtronic plc, Thubrikar Aortic Valve Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.